Anesthesia Coding Alert

Pain Management:

Say Good-Bye to Bilateral Charges for Chemodenervation

Plus: Add this new botulinum drug to your coding toolbox.The Medicare Physician Fee Schedule will introduce some changes April 1 that could have a big effect on your practice's bottom line, especially if you code for a pain management specialist who administers chemodenervation treatments.Bilateral Indicator Shifts to '2'Physicians sometimes use chemodenervation to help relieve symptoms of spasmodic torticollis (333.83), cerebral palsy (such as 343.x), or other conditions. CPT includes two codes for your use in these situations:64613 -- Chemodenervation of muscle(s); neck muscle(s) (e.g., for spasmodic torticollis, spasmodic dysphonia)64614 -- ... extremity(s) and/or trunk muscle(s) (e.g., for dystonia, cerebral palsy, multiple sclerosis).Previous versions of the physician fee schedule listed a bilateral status indicator of "1" for 64613 and 64614. That meant you could append modifier 50 (Bilateral procedure) and receive additional payment if your provider injected botulinum toxin into bilateral anatomic sites, such as the right and left upper extremities.Change: Medicare is [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Anesthesia Coding Alert

View All